atazanavir sulfate has been researched along with 3,9-bis((ethylthio)methyl)-k-252a in 1 studies
Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (3,9-bis((ethylthio)methyl)-k-252a) | Trials (3,9-bis((ethylthio)methyl)-k-252a) | Recent Studies (post-2010) (3,9-bis((ethylthio)methyl)-k-252a) |
---|---|---|---|---|---|
1,102 | 246 | 590 | 73 | 4 | 9 |
Protein | Taxonomy | atazanavir sulfate (IC50) | 3,9-bis((ethylthio)methyl)-k-252a (IC50) |
---|---|---|---|
Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.209 | |
Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.039 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.043 | |
Mitogen-activated protein kinase kinase kinase 9 | Homo sapiens (human) | 0.0413 | |
Protein delta homolog 1 | Homo sapiens (human) | 0.114 | |
Mitogen-activated protein kinase kinase kinase 10 | Homo sapiens (human) | 0.0412 | |
Mitogen-activated protein kinase kinase kinase 11 | Homo sapiens (human) | 0.0364 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dewhurst, S; DiFrancesco, R; Gelbard, HA; Gendelman, HE; Hochreiter, JS; Ma, Q; Maggirwar, SB; Morse, GD; Peterson, DR; Schifitto, G | 1 |
1 other study(ies) available for atazanavir sulfate and 3,9-bis((ethylthio)methyl)-k-252a
Article | Year |
---|---|
Pharmacokinetic interactions of CEP-1347 and atazanavir in HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Carbazoles; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Half-Life; HIV Infections; HIV-1; Humans; Male; MAP Kinase Kinase Kinases; Middle Aged; Nootropic Agents; Oligopeptides; Protein Kinase Inhibitors; Pyridines; Ritonavir | 2013 |